NOX 151
Latest Information Update: 16 Aug 2002
At a glance
- Originator Medinox
- Class Small molecules; Vascular disorder therapies
- Mechanism of Action Nitric oxide inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cerebrovascular disorders
Most Recent Events
- 19 Oct 1998 New profile
- 19 Oct 1998 Preclinical development for Cerebrovascular disorders in USA (Unknown route)